| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 665.23M | 1.09B | 1.27B | 719.63M | 860.76M |
| Gross Profit | 384.43M | 645.48M | 784.08M | 438.06M | 523.88M |
| EBITDA | 68.57M | -231.73M | 337.73M | -146.63M | 23.57M |
| Net Income | -362.19M | -382.28M | 10.34M | -212.78M | -49.43M |
Balance Sheet | |||||
| Total Assets | 5.49B | 6.07B | 6.78B | 6.65B | 7.54B |
| Cash, Cash Equivalents and Short-Term Investments | 1.12B | 1.21B | 1.19B | 1.22B | 1.63B |
| Total Debt | 115.12M | 181.65M | 237.81M | 349.08M | 798.94M |
| Total Liabilities | 383.96M | 472.56M | 711.52M | 592.86M | 1.13B |
| Stockholders Equity | 4.56B | 5.00B | 5.49B | 5.57B | 5.92B |
Cash Flow | |||||
| Free Cash Flow | 88.73M | 222.12M | 170.55M | 192.26M | 127.52M |
| Operating Cash Flow | 94.11M | 225.71M | 172.88M | 211.09M | 159.87M |
| Investing Cash Flow | 210.93M | 120.40M | -551.23M | -23.21M | -44.20M |
| Financing Cash Flow | -203.83M | -197.27M | -229.76M | -568.26M | -122.71M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$207.56B | 18.02 | 69.31% | 0.44% | 185.41% | 308.79% | |
65 Neutral | HK$1.59B | 8.40 | 4.75% | 6.25% | -1.22% | -38.58% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$1.10B | -2.83 | -8.76% | 9.09% | -39.09% | 5.19% | |
60 Neutral | HK$578.20M | -30.67 | 1.26% | 13.73% | -45.00% | -111.66% | |
59 Neutral | HK$218.00M | 4.03 | -42.82% | ― | -6.48% | -38.10% | |
43 Neutral | HK$190.12M | -0.96 | -10.60% | ― | 2.17% | -1.53% |